This article, published in Pharmafocus' April 2019 issue, features expert insights on the 21st Century Cures Act's relation to the expanding use of real-world evidence (RWE), as shared by ICON's Jim Carroll (VP, RWE) and Vicki Anastasi (VP & Global Head, RWE, Late Phase Research).
Download ArticleRelated Information
Webinar
Optimise Your RWE Investments
Blog
What is the Value of Real World Evidence in Oncology in HTA Appraisals?
Webinar
Real World Evidence Across the Product Lifecycle
Blog
Harnessing Technology to Maximise Real World Evidence Value
Blog
RWE Generation Cross Sectional Studies and Medical Chart Review
Webpage